Items where Author is "Dark, P."
Abel, K., Agnew, E., Amos, J. , Armstrong, N. 
ORCID: 0000-0003-4046-0119, Armstrong-James, D., Ashfield, T., Aston, S., Baillie, J. K., Baldwin, S., Barlow, G., Bartle, V., Bielicki, J., Brown, C., Carrol, E., Clements, M., Cooke, G., Dane, A., Dark, P., Day, J., de-Soyza, A., Dowsey, A., Evans, S., Eyre, D., Felton, T., Fowler, T., Foy, R., Gannon, K., Gerada, A., Goodman, A., Harman, T., Hayward, G., Holmes, A., Hopkins, S., Howard, P., Howard, A., Hsia, Y., Knight, G., Lemoine, N., Koh, J., Macgowan, A., Marwick, C., Moore, C., O’Brien, S., Oppong, R., Peacock, S., Pett, S., Pouwels, K., Queree, C., Rahman, N., Sculpher, M., Shallcross, L., Sharland, M., Singh, J., Stoddart, K., Thomas-Jones, E., Townsend, A., Ustianowski, A., Van Staa, T., Walker, S., White, P., Wilson, P., Buchan, I., Woods, B., Bower, P., Llewelyn, M. & Hope, W. (2024).
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework.
The Lancet Microbe, 5(5),
e500-e507.
doi: 10.1016/s2666-5247(24)00003-x
Walsh, T. S., Aitken, L. M. ORCID: 0000-0001-5722-9090, McKenzie, C. A. , Boyd, J., Macdonald, A., Giddings, A., Hope, D., Norrie, J., Weir, C., Parker, R. A., Lone, N. I., Emerson, L. M. ORCID: 0000-0002-4250-5758, Kydonaki, K., Creagh-Brown, B., Morris, S., McAuley, D. F., Dark, P., Wise, M. P., Gordon, A. C., Perkins, G., Reade, M., Blackwood, B., MacLullich, A., Glen, R. & Page, V. J. (2023).
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK.
BMJ Open, 13(12),
article number e078645.
doi: 10.1136/bmjopen-2023-078645
Hellyer, T. P., McAuley, D. F., Walsh, T. S. , Anderson, N. H., Conway Morris, A., Singh, S., Dark, P., Roy, A. I., Perkins, G. D., McMullan, R., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Wright, S. E., Kefala, K., O’Kane, C. M., Baudouin, S. V., Paterson, R. L., Rostron, A. J., Agus, A. M., Bannard-Smith, J., Robin, N. M., Welters, I. D., Bassford, C., Yates, B., Spencer, C., Laha, S. K., Hulme, J., Bonner, S., Linnett, V., Sonksen, J., Van Den Broeck, T., Boschman, G., Keenan, D. W. J., Scott, J., Allen, A. J., Phair, G., Parker, J., Bowett, S. A. & Simpson, A. J. (2020).
More research is required to understand factors influencing antibiotic prescribing in complex conditions like suspected ventilator-associated pneumonia.
Annals of Translational Medicine, 8(13),
article number 840.
doi: 10.21037/atm-20-3701
Hellyer, T. P., McAuley, D. F., Walsh, T. S. , Anderson, N., Conway Morris, A., Singh, S., Dark, P., Roy, A. I., Perkins, G. D., McMullan, R., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Wright, S. E., Kefala, K., O'Kane, C. M., Baudouin, S. V., Paterson, R. L., Rostron, A. J., Agus, A., Bannard-Smith, J., Robin, N. M., Welters, I. D., Bassford, C., Yates, B., Spencer, C., Laha, S. K., Hulme, J., Bonner, S., Linnett, V., Sonksen, J., Van Den Broeck, T., Boschman, G., Keenan, D. W. J., Scott, J., Allen, A. J., Phair, G., Parker, J., Bowett, S. A. & Simpson, A. J. (2019).
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation.
The Lancet Respiratory Medicine, 8(2),
pp. 182-191.
doi: 10.1016/s2213-2600(19)30367-4
Hellyer, T. P., Anderson, N. H., Parker, J. , Dark, P., Van Den Broeck, T., Singh, S., McMullan, R., Agus, A. M., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Gossain, S., Walsh, T. S., Perkins, G. D., Morris, A. C., McAuley, D. F. & Simpson, A. J. (2016).
Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.
Trials, 17(1),
article number 318.
doi: 10.1186/s13063-016-1442-x
Hellyer, T. P., Anderson, N. H., Parker, J. , Dark, P., Van Den Broeck, T., Singh, S., McMullan, R., Agus, A. M., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Gossain, S., Walsh, T. S., Perkins, G. D., Morris, A. C., McAuley, D. F. & Simpson, A. J. (2016).
Erratum to: ‘Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial’.
Trials, 17(1),
article number 465.
doi: 10.1186/s13063-016-1594-8